The only patented,hospital-grade
surface disinfecting system approved for fogging
EPA-registered Hypochlorous acid (HOCl).

Nevoa’s proprietary
Hypochlorous Acid solution

No Shelf life due to patented mixing cap  

pH neutral – less corrosive than bleach

Environmentally safe and responsible

Bar-coded for quality control and data tracking

FDA considers HOCl to be:

“…the form of free available chlorine having the highest bactericidal activity against a broad range of microorganisms…” U.S.FDA,2015

Independent Study Results

Percent of Pathogen Reduction

EPA Registered
Hospital Grade Disinfection

EPA Protocol

The EPA protocol for fogging device testing states that target(test) microorganisms must be placed in 20 different locations within the room (ceilings, walls, floors, under tables, etc.) to ensure the disinfectant is reaching ALL surfaces and is at least 99.99% effective at all locations.

​

EPA registration as a hospital-grade disinfectant required antimicrobial performance testing against

three primary microorganisms: S. aureus, S. enterica,

and P. aeruginosa. These three microorganisms were tested at each of the 20 room locations in triplicate

for a total of 180 total in-vitro samples.

​

​

​

  Research Publication

Impact of a Whole-Room

Atomizing Disinfection System on Healthcare Surface Contamination,

Pathogen Transfer, and Labor Efficiency

Key Findings

Efficiencies Gained

Our Mission Is Clear

Nevoa was created to tackle a major problem that

few outside of the healtcare environment are

aware of. Healthcare Acquired Infections (HAIs) are

the 5th leading cause of death in the United States.

One out of 25 patients get an infection they didn’t

have when they were admitted to a hospital.HAIs

cause up to100,000 deaths and exceed $45 Billion

in direct medical cost each year.Despite the

incredible efforts taken by hospital teams, these infections continue to be a problem. Nevoa believes

the answer is technology based solutions that

automate disinfection. Nevoa’s mission is to

transform the healthcare industry’s decades-old

manual disinfection and cleaning practices to

highly effective, automated protocols that provide superior disinfection at a reduced overall cost.

While other “whole room” disinfection technologies exist, they all come with significant shortcomings.

Some cannot sufficiently reach pathogens on every surface in a room – including difficult corners or behind and underneath furniture and equipment.

Other options use much more corrosive chemicals

that also require hours before you can safely

re-enter the room.The combination of the Nimbus Technology with Microburst Solution effectively

tackles the issue of HAIs while addressing the short comings of other whole-room disinfection

technologies.  

Nevoa
Leadership
Team 

The Nevoa leadership team brings decades of experience

from a diverse array of backgrounds.Together they have created a culture that encourages ideas, inspires passion,

and rewards hard work.They know that Nevoa brings a much needed and technologically advanced solution that will improve the lives of millions.

CEO

Mike Hudson

President

 Ernest Cunningham

Allen Arroyo

Director Of Marketing

Mark Hein

Business Development Director

Connie Addessi,RN

Product Development Director

Norm Lange

Press Releases

Nevoa Expands Sales
and distribution in Northeast
markets through partnership
with NEX Clean Specialty
Cleaning Solutions.

Nevoa Enters Sales
Partnership with Avante Health
Solutions, Strengthens National
Reach to Healthcare
Facilities.